FibroStic: A large confirmatory study for non-invasive biomarkers accuracy, if correctly interpreted

Journal of Hepatology

Volumn 55, Issue 1, 2011, Pages 233-

  Munteanu, Mona ^a   Ratziu, Vlad ^b   Poynard, Thierry ^b  

^a Biopredictive   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ELASTOGRAPHY; FIBROSCAN; FIBROTEST; HEPATITIS C; HUMAN; LETTER; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MORTALITY; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; VALIDATION PROCESS; VIRUS HEPATITIS;

ELASTICITY IMAGING TECHNIQUES; FEMALE; HEPATITIS, VIRAL, HUMAN; HUMANS; LIVER CIRRHOSIS; MALE;

EID: 79958844200     PISSN: 01688278     EISSN: 01688278     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.01.014     Document Type: Letter

References (9)

1. F. Degos, P. Perez, B. Roche, A. Mahmoudi, J. Asselineau, and H. Voitot FIBROSTIC study group. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study) J Hepatol 53 2010 1013 1021
2. L. Castera, J. Denis, G. Babany, and F. Roudot-Thoraval Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines? J Hepatol 46 2007 528 529 (Pubitemid 46201725)
3. T. Poynard, P. Halfon, L. Castera, M. Munteanu, F. Imbert-Bismut, and V. Ratziu FibroPaca Group. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages Clin Chem 53 2007 1615 1622 (Pubitemid 47340057)
4. J. Lambert, P. Halfon, G. Penaranda, P. Bedossa, P. Cacoub, and F. Carrat How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited Clin Chem 54 2008 1372 1378
5. P. Bedossa, D. Dargre, and V. Paradis Sampling variability of liver fibrosis in chronic hepatitis C Hepatology 38 2003 1449 1457 (Pubitemid 37466971)
6. T. Poynard, P. Ingiliz, L. Elkrief, M. Munteanu, P. Lebray, and R. Morra Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers PLoS One 3 2008 e3857
7. A.W. Rutjes, J.B. Reitsma, A. Coomarasamy, K.S. Khan, and P.M. Bossuyt Evaluation of diagnostic tests when there is no gold standard. A review of methods Health Technol Assess 11 2007 1 51
8. T. Poynard, M. Munteanu, and M. Colombo FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC (3) program J Hepatol 54 2011 586 587
9. Y. Ngo, M. Munteanu, D. Messous, F. Charlotte, F. Imbert-Bismut, and D. Thabut A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C Clin Chem 52 2006 1887 1896 (Pubitemid 44470696)